Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
about
Urinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjectsCysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in malesOdd couple: The unexpected partnership of glucocorticoid hormones and cysteinyl-leukotrienes in the extrinsic regulation of murine bone-marrow eosinopoiesis.Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisPharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.Interactions of obstructive sleep-disordered breathing with recurrent wheezing or asthma and their effects on sleep quality.Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.Pharmacotherapy for the treatment of asthma: current treatment options and future directions.Respiratory syncytial virus induces leukotriene C4 synthase expression in bronchial epithelial cells.Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma.Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes.The relation between obesity and asthmatic airway inflammation.The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency.
P2860
Q28168215-A2D9F2DB-2667-42D7-BCE3-2CD3673EEEA0Q28196697-31842585-72AD-4871-A1A9-28F38215C1D7Q36297766-41552E7D-4958-4A0E-8C38-55244F9FD832Q37077214-EED52E19-4900-41D4-8654-6D162477457EQ37078077-E1C8F929-57D8-4F97-B6C1-6A9F74010226Q37179472-2CDE655A-130D-4B65-95A0-6217B8586409Q37910094-F4A7C8B7-5AA2-49A1-8D7F-9348A17E9039Q38172278-08214ECE-205E-4884-B858-E652A16C9831Q38579908-B4F3FAF9-5B24-4416-9E7C-AFFB3AAFD33AQ39063567-5116AC87-06B6-4CB3-8D01-4A1BD82EBFBFQ42934398-CCFB5AB5-B7B1-49DB-8658-852D00A25624Q44741246-96FD45C5-D721-4E82-ADC0-06E65B3C8EF1Q45233080-59E042BB-021F-408D-8360-BCE66AB64D1FQ47943640-9AFD3608-6715-4A2A-9AC6-3E48392B5BC7Q53541065-95C1CE7A-9FE3-428F-967A-1EF63870F21A
P2860
Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cysteinyl leukotriene interact ...... ds during airway inflammation.
@en
type
label
Cysteinyl leukotriene interact ...... ds during airway inflammation.
@en
prefLabel
Cysteinyl leukotriene interact ...... ds during airway inflammation.
@en
P356
P1476
Cysteinyl leukotriene interact ...... ds during airway inflammation.
@en
P2093
Anthony P Sampson
P304
S37-42; discussion S43-8
P356
10.1067/MAI.2003.23
P407
P433
P577
2003-01-01T00:00:00Z